Goji berry is a famous edible and medicinal substance around the world.In this research,15 phenylpropionyl phenylethylamine derivatives(1-15),in cluding one new compound(1),were separated and identified from g oji ber...Goji berry is a famous edible and medicinal substance around the world.In this research,15 phenylpropionyl phenylethylamine derivatives(1-15),in cluding one new compound(1),were separated and identified from g oji berry.All isolates were elucidated via ex tensive nuclear magnetic resonance spectral analyses and chemical techniques.Six known isolates were first obtained from Lycium genus.Six isolates were effectively split in to double chromatographic peaks accompanied by the basically identical areas,indicating they belong to racemates.The oxygen radical absorbance capacity(ORAC)experiment indicated that all isolates displayed a capacity of scavenging free radicals,and most of them exhibited higher ORAC than epigallocatechingallate.In ethanol/palmitic acid-established in vitro hepatocyte injury model,four phenylpropionyl phenylethylamine derivatives(1,2,9,and 15)significantly alleviated hepatocyte injury,among which compound 1 exerted the strongest protective activity.Notably,the hepatoprotective effect of compound 1 was further confirmed in ethanol-established liver damage mouse model,reflected by the reduction of lipid accumulation and the attenuation of pathological alteration.Combined with the in vitro results,the in vivo observations suggested that compound 1 suppressed cell apoptosis and the outburst of inflammation.Our findings provided first-hand evidence proving that goji berry-derived phenylpropionyl phenylethylamine derivatives hold a potential in treating alcoholic liver disease.展开更多
A new approach for preparation ol various substituted phenylethylamines from the corresponding nitro compounds with iron powder and NH4Cl in 75% aqueous ethanol solution was developed.
The photovoltaic performance of perovskite sloar cells(PSCs)is strongly dependent on the crystallinity,morphorlogy and defects of perovskite films.In the present work,a novel strategy was developed to fabricate the hi...The photovoltaic performance of perovskite sloar cells(PSCs)is strongly dependent on the crystallinity,morphorlogy and defects of perovskite films.In the present work,a novel strategy was developed to fabricate the high quality CsPbI3 inorganic perovskite by tuning the growth dynamics of CsPbI3 by pretreatment of fresh CsPbI3 films with phenylethylamine iodide(PEAI).The PEAI can mediate the phase transformation from 1D(DMAPbI3)(DMA:dimethylammonium)to 3D CsPbI3 all-inorganic perovskite films via the PEA2CsPb2I7 of 2D perovskite intermediate phase,resulting in highly crystalline CsPbI3 perovskite films with remarkably enlarged grains and reduced defects.The as-achieved highly crystalline CsPbI3 inorganic perovskite not only exhibited improved phase stability but also significant reduced defects.The perovskite solar cells based on these CsPbI3 thin films exhibited a champion efficiency of 17.08%,much higher than those prepared through posttreatment or direct addition of PEAI into CsPbI3 precursor solution.This work not only developed an effective strategy to prepare high crystalline CsPbI3 film and highly efficient CsPbI3-based all-inorganic PSCs,but also unraveled the mediation mechanism of CsPbI3by pre-treatment of PEAI,shedding light for further development of high perfomance perovskite-based optoelectronics.展开更多
基金funded via National Natural Science Foundation of China(81925037,82321004,U22A20371,and 82273801)Guangdong Major Project of Basic and Applied Basic Research(2023B0303000026)+6 种基金Guangdong International Science and Technology Cooperation Base(2021A0505020015)Innovative and Research Teams Project of Guangdong Higher Education Institution(2021KCXTD001)Guangdong Basic and Applied Basic Research Foundation(2022A1515012071)Young Elite Scientists Sponsorship Program by China Association of Chinese Medicine(2021-QNRC2-B21)Guangdong-Hong Kong-Macao Universities Joint Laboratory for the Internationalization of Traditional Chinese Medicine(2023LSYS002)Guangzhou Key Laboratory of Traditional Chinese Medicine&Disease Susceptibility(2024A03J090)Science and Technology Program of Guangzhou(201707010414,202201020066,and 2024A04J9955)。
文摘Goji berry is a famous edible and medicinal substance around the world.In this research,15 phenylpropionyl phenylethylamine derivatives(1-15),in cluding one new compound(1),were separated and identified from g oji berry.All isolates were elucidated via ex tensive nuclear magnetic resonance spectral analyses and chemical techniques.Six known isolates were first obtained from Lycium genus.Six isolates were effectively split in to double chromatographic peaks accompanied by the basically identical areas,indicating they belong to racemates.The oxygen radical absorbance capacity(ORAC)experiment indicated that all isolates displayed a capacity of scavenging free radicals,and most of them exhibited higher ORAC than epigallocatechingallate.In ethanol/palmitic acid-established in vitro hepatocyte injury model,four phenylpropionyl phenylethylamine derivatives(1,2,9,and 15)significantly alleviated hepatocyte injury,among which compound 1 exerted the strongest protective activity.Notably,the hepatoprotective effect of compound 1 was further confirmed in ethanol-established liver damage mouse model,reflected by the reduction of lipid accumulation and the attenuation of pathological alteration.Combined with the in vitro results,the in vivo observations suggested that compound 1 suppressed cell apoptosis and the outburst of inflammation.Our findings provided first-hand evidence proving that goji berry-derived phenylpropionyl phenylethylamine derivatives hold a potential in treating alcoholic liver disease.
文摘A new approach for preparation ol various substituted phenylethylamines from the corresponding nitro compounds with iron powder and NH4Cl in 75% aqueous ethanol solution was developed.
基金supported by the National Natural Science Foundation of China(No.51602106)。
文摘The photovoltaic performance of perovskite sloar cells(PSCs)is strongly dependent on the crystallinity,morphorlogy and defects of perovskite films.In the present work,a novel strategy was developed to fabricate the high quality CsPbI3 inorganic perovskite by tuning the growth dynamics of CsPbI3 by pretreatment of fresh CsPbI3 films with phenylethylamine iodide(PEAI).The PEAI can mediate the phase transformation from 1D(DMAPbI3)(DMA:dimethylammonium)to 3D CsPbI3 all-inorganic perovskite films via the PEA2CsPb2I7 of 2D perovskite intermediate phase,resulting in highly crystalline CsPbI3 perovskite films with remarkably enlarged grains and reduced defects.The as-achieved highly crystalline CsPbI3 inorganic perovskite not only exhibited improved phase stability but also significant reduced defects.The perovskite solar cells based on these CsPbI3 thin films exhibited a champion efficiency of 17.08%,much higher than those prepared through posttreatment or direct addition of PEAI into CsPbI3 precursor solution.This work not only developed an effective strategy to prepare high crystalline CsPbI3 film and highly efficient CsPbI3-based all-inorganic PSCs,but also unraveled the mediation mechanism of CsPbI3by pre-treatment of PEAI,shedding light for further development of high perfomance perovskite-based optoelectronics.
